Carlo
PeopleProgramsSpecialtiesInstitutionsPricing
Sign inJoin waitlistJoin the waitlist
Carlo

the ai that helps you match

Part of the Carlo family
© 2026 Carlo Finance, Inc.
PeopleProgramsSpecialtiesInstitutionsPricingMethodologyPrivacyTerms
Back to overview

Indiana University School of Medicine Gynecologic Oncology

Fellowship · Indianapolis, IN

Sponsored by Indiana University School of Medicine · Director Sharon Robertson

Research

Works by its people
184
Authors
17
First-author works
57
Citations
7,741
20112026

Topics

  • Endometrial and Cervical Cancer Treatments 44
  • Ovarian cancer diagnosis and treatment 23
  • Pelvic floor disorders treatments 7
  • Cervical Cancer and HPV Research 5
  • Immunotherapy and Immune Responses 5
  • Uterine Myomas and Treatments 5
  • Reproductive Health and Contraception 4
  • Pain Management and Treatment 3
  • Palliative Care and End-of-Life Issues 3
  • PARP inhibition in cancer therapy 3
  • Pregnancy and preeclampsia studies 3
  • Cancer survivorship and care 2

Most cited

  1. Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.

    The New England journal of medicine · 2023 · 703 citations · Lisa Landrum

  2. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

    The New England journal of medicine · 2023 · 633 citations · Lisa Landrum

  3. NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.

    Journal of the National Comprehensive Cancer Network : JNCCN · 2024 · 127 citations · Sharon Robertson

  4. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2025.

    Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 55 citations · Lisa Landrum

  5. Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial.

    Nature medicine · 2025 · 59 citations · Lisa Landrum

  6. Overall survival in patients with endometrial cancer treated with dostarlimab plus carboplatin-paclitaxel in the randomized ENGOT-EN6/GOG-3031/RUBY trial.

    Annals of oncology : official journal of the European Society for Medical Oncology · 2024 · 109 citations · Lisa Landrum

  7. Cervical Cancer, Version 2.2026, NCCN Clinical Practice Guidelines In Oncology.

    Journal of the National Comprehensive Cancer Network : JNCCN · 2025 · 25 citations · Lisa Landrum

  8. Evaluation of efficacy and fertility after nonradical surgical therapy (extra fascial hysterectomy or cone biopsy, with pelvic lymphadenectomy) for stage IA1, IA2, and IB1 cervical cancer (GOG-0278).

    Gynecologic oncology · 2025 · 17 citations · Sharon Robertson